IBEX (NASDAQ:IBEX) Director Patrick Mcginnis Sells 2,500 Shares of Stock

IBEX Limited (NASDAQ:IBEX) Director Patrick McGinnis sold 2,500 shares of IBEX stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $50.48, for a total value of $126,200.00. Following the transaction, the director owned 4,585 shares in the company, valued at $231,450.80. This trade represents a 35.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

IBEX Stock Performance

Shares of IBEX opened at $52.23 on Wednesday. The stock has a 50 day simple moving average of $43.52 and a 200 day simple moving average of $34.63. IBEX Limited has a 52-week low of $25.94 and a 52-week high of $52.29. The firm has a market capitalization of $696.23 million, a PE ratio of 15.83 and a beta of 0.74.

IBEX (NASDAQ:IBEX) last posted its earnings results on Thursday, November 5th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.20. The business had revenue of $175.23 million during the quarter, compared to analysts’ expectations of $169.31 million. IBEX had a return on equity of 29.10% and a net margin of 7.34%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Robert W. Baird increased their price objective on shares of IBEX from $40.00 to $44.00 and gave the stock a “neutral” rating in a research report on Monday, September 28th. Royal Bank Of Canada boosted their price objective on shares of IBEX from $40.00 to $45.00 and gave the company a “sector perform” rating in a research report on Tuesday. Weiss Ratings raised shares of IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, October 12th. Finally, Wall Street Zen raised shares of IBEX from a “buy” rating to a “strong-buy” rating in a research note on Saturday. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $44.50.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Bullock Wealth Management Group acquired a new stake in IBEX in the 3rd quarter valued at approximately $36,000. Signaturefd LLC boosted its position in IBEX by 272.4% during the 3rd quarter. Signaturefd LLC now owns 1,784 shares of the company’s stock worth $77,000 after acquiring an additional 1,305 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in IBEX during the 3rd quarter worth approximately $85,000. D Orazio & Associates Inc. acquired a new position in IBEX during the 3rd quarter worth approximately $213,000. Finally, Vise Technologies Inc. bought a new position in shares of IBEX during the 3rd quarter worth approximately $223,000. 81.24% of the stock is currently owned by institutional investors.

Key Headlines Impacting IBEX

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

IBEX Company Profile

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.